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Livestock breeding for the 21st century: the promise of the
editing revolution
Chris PROUDFOOT, Gus MCFARLANE, Bruce WHITELAW, Simon LILLICO (✉)
The Roslin Institute and Royal (Dick) School of Veterinary Studies, University of Edinburgh, Easter Bush, Midlothian, EH25 9RG, UK
Abstract In recent years there has been a veritable
explosion in the use of genome editors to create site-
speciﬁc changes, both in vitro and in vivo, to the genomes
of a multitude of species for both basic research and
biotechnology. Livestock, which form a vital component
of most societies, are no exception. While selective
breeding has been hugely successful at enhancing some
production traits, the rate of progress is often slow and is
limited to variants that exist within the breeding popula-
tion. Genome editing provides the potential to move traits
between breeds, in a single generation, with no impact on
existing productivity or to develop de novo phenotypes
that tackle intractable issues such as disease. As such,
genome editors provide huge potential for ongoing live-
stock development programs in light of increased demand
and disease challenge. This review will highlight some of
the more notable agricultural applications of this technol-
ogy in livestock.
Keywords cattle, pig, sheep, chicken, aquaculture,
CRISPR
1 Introduction
Genetic selection was for millennia an unintended
consequence of domestication, with sustained pressure
linking reproductive ﬁtness to desirable traits inevitably
resulting in domesticated animals becoming both physi-
cally and genetically distinct from their wild ancestors. It is
only relatively recently that humans have come to
understand the sometimes-complex relationship between
genotype and phenotype and exploit this in a more direct
manner. Genomic selection tools now form the basis for
many livestock breeding programs, and the associated
productivity gains seen across the industry have been
astounding. In parallel to genetic improvement programs,
molecular biology tools have been developed that allow
the introduction of precise alterations to the DNA in situ,
enabling intentional de novomodiﬁcation of the genome as
opposed to selection for observed variants.
These are tools commonly referred to as genome editors
and can be divided into three groups: ZFNs (zinc ﬁnger
nucleases), TALENs (transcription activator-like effector
nucleases) and CRISPR-Cas (clustered regularly inter-
spaced short palindromic repeats––CRISPR-associated).
ZFNs are proteins composed of a short array of zinc ﬁnger
(ZF) DNA binding motifs fused to one half of the dimeric
FokI nuclease. ZFNs are usually applied in pairs, with each
of the ZF arrays binding one strand of the DNA, facilitating
dimerization of the nuclease and cutting of the intervening
DNA. ZFNs typically have good sequence speciﬁcity but
are both challenging and expensive to produce, and as such
are no longer the reagent of choice for most research
groups. TALENs, like ZFNs, are composed of an array of
programmable DNA binding domains fused to FokI, and
like ZFNs are employed as pairs in order to cleave the
target DNA. Unlike ZFNs, TALENs are relatively easy to
design and cost-effective to construct using basic mole-
cular biology reagents, and as such saw signiﬁcant uptake.
However, they have been largely supplanted by the
CRISPR-Cas system. Unlike ZFNs and TALENs that
rely on designed proteins to confer speciﬁcity for the DNA
target sequence, CRISPR-Cas relies on a small RNA
complexed to the Cas nuclease for target site recognition.
As the binding speciﬁcity relies only onWatson-Crick base
pairing, guide RNA design is simple and computational
tools predicting both on- and off-target speciﬁcity
abound[1]. Importantly, because the Cas nuclease compo-
nent of the CRISPR-Cas system remains constant it is
conceptually easy to multiplex editing events, making this
toolset ideal for tackling genetic alterations involving
multiple loci. CRISPR-like systems are being discovered
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in an ever increasing number of bacteria and archea and it
is likely that initial discoveries have only scratched the
surface of the available toolbox[2,3].
The number of publications reporting application of
editing in model species broadly correlates with discovery
of the tools and their ease of use. Before 2010, editing was
almost a niche technique, limited to laboratories that could
afford to work with ZFNs. Following the ﬁrst description
of the utility of TALENs[4] there was a dramatic increase in
the utilization of editing relative to the more proven
transgenic technologies, but it was not until the advent of
the CRISPR system[5–7] that editing became a molecular
biology mainstay. In the 7 years since the initial reports
there has been continuous development of CRISPR tools,
improving activity, speciﬁcity and utility and resulting in
unprecedented uptake of the technology in laboratories
across the globe. In the ﬁrst 6 months of 2019 there were
over 2500 research articles that relied on CRISPR as a core
technique to deliver their scientiﬁc output.
2 Application in livestock
Given the extended generation time and increased costs
associated with livestock research it is unsurprising that
examples of genome editing in this ﬁeld have lagged
slightly behind the rodent community. While not the focus
of this review, it is worth noting the ﬁrst demonstration of
editing an endogenous gene in a livestock species was for
the purpose of developing pigs for xenotransplantation. In
2011, Hauschild et al.[8] reported ZFN-mediated disruption
of the GGTA1 gene encoding the enzyme α1,3-galactosyl-
transferase that adds Gal epitopes to the porcine cell
surface. The researchers were able to employ negative
selection for the presence of Gal on the transfected primary
ﬁbroblasts, dramatically improving the probability that the
cloned piglets would be biallelic for gene disruption. As an
alternative to cloning, edited animals have been produced
by directly microinjecting mRNAs encoding the genome
editor reagents into the cytoplasm of an early zygote[9].
Litter sizes and viability are good with this approach, and
while early demonstrations had relatively low editing
frequency, evolution of the tools and reﬁnement in delivery
has resulted in substantive improvements[10,11]. A combi-
nation of SCNT followed by zygote microinjection with
Cas9 ribonucleoprotein (Cas9 protein pre-complexed with
sgRNA) has also been shown to be a very efﬁcient strategy
for generation of genome edited pigs[12].
Disrupting genes by way of targeted non-homologous
end joining (NHEJ) has proven a robust strategy for
achieving deﬁned phenotypic outcomes. However, the
number of agricultural traits for which this will be a viable
approach is likely to be limited, with more subtle changes
to gene function a desirable outcome in most cases. In an
age where access to large data sets comprising sequence
information and/or biometrics is becoming increasingly
common, understanding of the genome-phenome relation-
ship for many traits is expanding. This will undoubtedly
yield opportunities to move relevant allelic variants
directly between breeds without the genetic drag asso-
ciated with conventional breeding. Editor-mediated allele
modiﬁcation has been used to introduce natural variants
observed in other breeds[13,14] and even other species[15],
making these tools viable additions to ongoing breeding
projects.
3 Welfare
Livestock in modern agricultural systems often engage in
behaviors natural to their wild forebears. While some of
these activities are perceived as beneﬁcial to the welfare of
the individuals and therefore often actively encouraged
(e.g., active foraging or nesting behavior in pigs), others
can be detrimental to both the animals and the farmers.
This is exempliﬁed in cattle, where natural behavior
includes head butting. In beef cattle breeds that lack horns
(termed polled) this is rarely problematic. However, in
dairy breeds, where most cattle are naturally horned,
signiﬁcant physical harm can ensue. Consequently, it is
common to burn out the horn buds of young calves with
either heat or caustic pastes, or to physically cut the horns
from older animals. In addition to being painful for the
animals and causing stress to both the cattle and their
handlers, these interventions incur a monetary cost. It is
estimated that 14 million cattle are disbudded or dehorned
annually in the USA alone. The genetics of polled are well
understood, and it is possible to propagate polled alleles
through a population using standard breeding processes.
The problem with this approach is that dissemination of
elite genetics in the dairy industry is predominantly
through AI, and the dairy bulls with the highest breeding
values are horned. Introduction of polled would, in the
short-term at least, likely be at the detriment of
productivity. Genome editing offers a potential solution
to this tradeoff. TALENs have been used to introduce the
Celtic polled (Pc) allele (duplication of 212 bp that
replaces 10 bp) into ﬁbroblasts derived from a horned dairy
bull[16]. Cloning from these cells resulted in calves that
were genetically identical to the father with the exception
of the targeted locus, and crucially were phenotypically
polled[13]. Subsequent whole-genome sequence analysis of
polled bull RCI002 revealed that in addition to the biallelic
introgression of Pc, one allele also contained an uninten-
tional insertion of the plasmid HDR vector proximal to the
target site[17]. This issue of unexpected plasmid insertion
associated with editor-mediated targeting has been
reported previously[15], and can be resolved simply by
selection among second generation segregants. Indeed,
semen from RCI002 was used to artiﬁcially inseminate a
cohort of horned Hereford cows, resulting in all six calves
displaying the polled phenotype (Pc is dominant). The Pc
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and Pc-plasmid alleles segregated as expected during
breeding, resulting in two offspring with Pc and four with
Pc-plasmid[17].
4 Production traits
Myostatin is a negative regulator of skeletal muscle
growth, and when it comes to monogenic livestock traits
of large effect there are few that can compete. Breeds that
have been selected for increased muscle mass, such as
Belgian Blue cattle, have mutations within the coding
sequence of the myostatin gene[18], while others, such as
Texel sheep, have reduced myostatin expression due to
altered non-coding sequence[19]. Given the striking
phenotype that can be achieved by perturbing myostatin
expression, coupled with its perceived value for agricul-
ture, it is not surprising that it has now been edited in most
major livestock species including cattle[20], sheep[21],
pig[22] and goat[11]. It is important to note that such
animals require a more energy-dense diet than comparators
and as such are not suitable for all agricultural systems.
Several genes have been associated with proliﬁcacy in
sheep, including FecB, FecG and FecX. While allelic
variants of FecG and FecX have both been associated with
increased lambing rates in heterozygous females, homo-
zygote females are infertile. By contrast, FecB has additive
effect with homozygote females having a higher lambing
rate than their heterozygous counterparts[23]. A mutation in
the 3′UTR of the FecB gene has similarly been associated
with increased proliﬁcacy in goats[24]. Improved lambing
rate is desirable in some husbandry systems, and a
CRISPR/Cas-induced point mutation has been used to
introduce the Q249R mutation into the FecB of Chinese
Tan sheep[14].
Milk is an excellent source of nutrition, but milk from
livestock contains a number of proteins known to be
associated with allergies (as opposed to lactose, which is
associated with intolerance), including the most abundant
proteins in milk such as the caseins, α-lactalbumin and
β-lactoglobulin. Bovine milk is one of the most common
food allergens, affecting up to 3% of infants globally, with
milk from sheep, goats and buffalo also having the
potential to elicit an adverse immune response. A cow
lacking β-lactoglobulin was engineered by inducing a
small, targeted deletion and a premature stop codon
proximal to translation start of the gene[25]. Analysis of
milk from this animal conﬁrmed that β-lactoglobulin was
no longer expressed. Similar abrogation of β-lactoglobulin
expression has been demonstrated in goats[26,27]. It is likely
implausible at this time to remove all potential allergens
from milk, as simple deletion of the respective genes
would likely cause signiﬁcant detriment to milk produc-
tion. However, the work above clearly demonstrates the
potential for generating milk and milk products with
reduced allergenic potential.
5 Disease resistance
Disease burden is one of the most signiﬁcant challenges to
livestock husbandry. Where available, appropriate vac-
cines can signiﬁcantly reduce losses, but cost implications
and the presence of a reliable cold-chain can prove
signiﬁcant barriers to application in some regions. There
are additional logistical challenges to vaccination out-with
commercial settings. Many viral infections are associated
with secondary bacterial infections, contributing signiﬁ-
cantly to use of antimicrobials in agriculture.
Porcine reproductive and respiratory syndrome (PRRS)
is a global disease of pigs resulting in signiﬁcant economic
losses to the swine industry. The two main genotypes of
PRRS virus (PRRSV) share about 60% sequence identity,
with further genetic disparity between isolates within each
genotype. Control is generally with modiﬁed live vaccines,
but cross-protection between viral strains is poor[28]. In
vitro studies identiﬁed CD163, a member of the scavenger
receptor cysteine-rich superfamily, as necessary for estab-
lishment of a productive viral infection[29]. Production of
edited pigs with a functional knockout of porcine CD163
demonstrated for the ﬁrst time in vivo a robust genetic
approach to confer resistance to PRRSV infection[30]. The
CD163 protein has a number of important biological
functions including hemoglobin/haptoglobin recycling.
CD163 presents nine extracellular domains on the surface
of monocytes and macrophages, with the virus interacting
speciﬁcally with domain number ﬁve. By deleting exon 7,
which encodes the entirety of domain ﬁve, it proved
possible to produce edited pigs that expressed a modiﬁed
CD163 protein that retained these functions. Crucially,
these pigs were also resistant to challenge with PRRSV[31].
Aminopeptidase N (AP-N, also known as CD13), a zinc-
dependent type II metalloprotease situated on the plasma
membrane of many cell types, cleaves N-terminal neutral
amino acids. It is involved in a variety of cellular processes
including peptide metabolism, angiogenesis, cell motility
and adhesion, and has elevated expression in many
cancers. It is enriched on the apical membrane of
enterocytes where it has a role in the digestion of peptides.
AP-N was identiﬁed as a putative receptor for the porcine
coronavirus transmissible gastroenteritis virus (TGEV)[32],
and the human coronavirus 229E[33]. Despite subsequent
in vitro experiments supporting these associations, in vivo
biological relevance remained unproven. Injection of
porcine zygotes with CRISPR/Cas9 reagents targeting
the ﬁrst coding exon of ANPEP, the gene encoding AP-N,
resulted in piglets lacking AP-N expression[34]. Challenge
of these animals with TGEV conﬁrmed that AP-N was
indeed required for productive viral infection. AP-N is
involved in a several normal biological processes, and
while no adverse effect associated with AP-N knockout
was observed in the null pigs it is likely that an approach
akin to the CD163 domain deletion, whereby viral entry is
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inhibited and the functions of the remaining protein
retained, would be beneﬁcial for production animals.
In vitro studies also identiﬁed AP-N as the putative entry
receptor for porcine epidemic diarrhea virus (PEDV)[35,36],
while other research contradicted these ﬁndings[37,38].
Challenge of the AP-N null piglets categorically demon-
strated that AP-N was not required for PEDV infection in
pigs.
6 Aquaculture
The ﬁeld of aquaculture was quick to adopt genome editor
technology, with many groups reporting on its application
in a diverse range of species (reviewed in Gratacap
et al.[39]). Li and colleagues were among the ﬁrst groups to
highlight this potential[40], demonstrating efﬁcient editing
of a number of genes in Nile tilapia, one of the most
important aquaculture species globally. The establishment
of effective culture conditions for pluripotent tilapia
spermatogonial stem cells (SSCs) could prove to be a
signiﬁcant development[41], as it offers the opportunity to
sequentially introduce more complex changes into the
germline than would be practical by the direct injection of
the reagents into zygotes.
As discussed above for mammals, myostatin has also
proven a popular target in ﬁsh. Knockout of myostatin a
(MSTNa) in channel catﬁsh[42] or myostatin ba (MSTNba)
in common carp[43] resulted in an enhanced growth rate,
with corresponding increases in size and number of muscle
ﬁbers. It should be noted that while mammals have a single
MSTN gene, tetraploid species such as the carp have a
duplication(s) resulting in two or more copies of myostatin.
In addition to expression in skeletal muscle, myostatin in
ﬁsh has been reported in numerous other tissues,
suggesting functions beyond regulation of muscle growth.
Indeed, knockout of both genes in zebraﬁsh is associated
with impaired function of the immune system[44].
Encouragingly for those working in this sector, the
Argentine National Advisory Commission on Agricultural
Biotechnology has recently ruled that AquaBounty’s FLT
01 line of gene-edited tilapia will not be regulated as a
GMO, as they contain no new DNA.
Biosecurity is a longstanding concern in aquaculture,
with the genetic identity and diversity of wild populations
facing threat from escapees. Genome editing could further
exacerbate this risk, but also offers potential solutions. By
using the CRISPR/Cas9 system to knockout dead end
(dnd), a gene required for primordial germ cell (PGC)
formation, genetically infertile Atlantic salmon have been
produced[45].
In the ﬁeld of aquaculture, genome editing has not been
limited to ﬁsh. Shrimp farming contributes billions of
dollars to the global economy, and genome editing has
been demonstrated in the ridgetail white prawn[46]. By
microinjecting zygotes with Cas9 mRNA and a guide
targeting the gene encoding molt-inhibiting hormone,
researchers demonstrated a signiﬁcantly reduced meta-
morphosis time in larvae and an increase in body length in
adults. Proof-of-concept has also been demonstrated in
oysters, with editing of either myostatin or the transcription
factor TWIST2[47]. These diverse examples highlight the
range of opportunities genome editing could offer in an
agricultural sector that is rapidly expanding.
7 In vitro germline editing
In chickens the egg is laid about 24 h post fertilization, at
which point the blastodermal disk is composed of around
60000 cells. Accessing the embryo before lay poses
signiﬁcant challenges, and this constraint to modiﬁcation
of the single-celled zygote has proven an obstacle to
genetic alteration of poultry. At 48–60 h post-incubation
chicken PGCs, the precursor cells of the gametes, migrate
through the blood stream from the germinal crescent and
begin to populate the developing gonads. These cells can
be isolated, and in vitro culture conditions have been
developed that allow their long-term propagation with
retention of in vivo germline competence[48]. Germline
transmission of transplanted PGCs ranged from < 1% to
86%, at least in part due to inherent competition with the
endogenous PGCs of the recipient. Editor-mediated
targeting of the DDX4 gene in cultured PGCs enabled
the production of sterile female chickens[49] and transfer of
cultured PGCs to these surrogates in ovo resulted in all
subsequent offspring being derived from the transplanted
cells[50]. As with the tilapia SSCs discussed above, the
ability to culture poultry PGCs for extended periods
potentiates sequential editing of multiple genes.
In mammals, SSCs can be isolated from the testes of
adult livestock. While there are numerous reports detailing
culture and characterization of these cells, the deﬁnitive
proof––functional colonization of a recipient gonad––
remains lacking. As a step toward this goal, CRISPR-
mediated disruption of the Nanos2 gene was used to
generate male pigs with an empty SSC niche[10]. As with
theDDX4 knockout chickens, these animals could improve
frequency of germline transmission of transplanted SSCs
by circumventing competition with endogenous cells.
8 Summary and future perspective
Genome editing has rapidly become a mainstream tool in
biological research. The ability to generate site-speciﬁc
changes to the genome allows researchers to ask funda-
mental questions about gene function, to move allelic
variants between breeds or species, or to create novel
phenotypes. Breaking a gene with these reagents to create
functional knockouts is relatively simple (e.g., myostatin
or ANPEP), as is inducing modest changes at the target site
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(e.g., CD163 exon 7 removal or Celtic polled insertion).
The agricultural traits exploited with this technology thus
far have involved single target loci with large effects, and
while these have served as great exemplars of its potential
there are a ﬁnite number of such low-hanging fruits. Many
production traits are known to be inﬂuenced by a multitude
of genes with much smaller effect. As understanding of the
genome/phenome relationship develops, it seems likely
that polygenic modiﬁcation will become a desirable goal.
Given the current momentum in both academic and
commercial sectors to develop new and improved tools,
multiplexed editing is edging closer to being a tenable
solution with clear potential to positively impact genetic
gain[51]. Time will tell if achieving robust multiplex editing
will require cell-based protocols or if direct embryo
injection will remain an optimal approach.
While genome editing clearly holds great potential, there
remain relatively few examples of manipulation of
endogenous genes of agricultural signiﬁcance. This is, at
least in part, due to a lack of veriﬁed targets. Many research
groups are now employing genome-wide CRISPR-based
screens to identify host genes that can be manipulated to
improve disease resistance. Many different screens can be
devised, from knocking out gene function through to
elevating gene activity. In addition, to screen the entire
gene repertoire, selective screens can be developed that test
speciﬁc types of regulatory control elements or are
combined with selective overexpression platforms. It is
tempting to predict these approaches will quickly throw up
many candidate loci, while recognizing that each candidate
will probably require in vivo validation either through
extensive genetic studies or by editing the candidate gene
in the target animal. While application of such screens for
disease resistance traits is conceptually simple, developing
appropriate assays for other agricultural traits could prove
signiﬁcantly more challenging.
Genome editing technology attracts considerable public
interest with voices both for and against. Opinions are
likely to differ substantially depending on societal
perspectives including but not limited to afﬂuence, age,
religion and geography. For many, issues related to
technology do not elicit a yes or no response but a case-
by-case deliberation. Reports of surveys of public opinion
are starting to emerge[52–54]. These show general support
for application of the technology, with a parallel cry for
more information so that informed opinions can be
developed[55]. Recognized as a topic of public interest,
the Nufﬁeld Council on Bioethics (UK) is currently
preparing a report on ‘Genome Editing and Farmed
Animals’ which will provide a yardstick on the ethical
aspect of this technology in livestock.
Genome editing is here to stay. Initial projects have
shown biological success with some progressing through
the regulatory landscape. It is now time to expand the
cohort of traits that can beneﬁt from this transformative
technology.
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